Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Sell
31,340
-77,810
-71% -$9.11M 0.29% 61
2026
Q1
$13.1M Sell
109,150
-1,193
-1% -$138K 1.09% 29
2025
Q4
$11.6M Sell
110,343
-219
-0.2% -$20.6K 0.92% 37
2025
Q3
$9.28M Sell
110,562
-535
-0.5% -$44.1K 0.84% 40
2025
Q2
$8.79M Buy
111,097
+566
+0.5% +$45K 0.87% 41
2025
Q1
$9.92M Buy
110,531
+785
+0.7% +$73.3K 1.05% 30
2024
Q4
$10.9M Sell
109,746
-531
-0.5% -$54.7K 1.15% 33
2024
Q3
$12.5M Buy
110,277
+30
+0% +$3.56K 1.34% 27
2024
Q2
$13.6M Sell
110,247
-1,896
-2% -$244K 1.57% 22
2024
Q1
$14.8M Sell
112,143
-1,549
-1% -$191K 1.76% 20
2023
Q4
$12.4M Sell
113,692
-1,351
-1% -$140K 1.6% 23
2023
Q3
$11.8M Sell
115,043
-1,534
-1% -$165K 1.78% 19
2023
Q2
$13.5M Sell
116,577
-719
-0.6% -$81.6K 1.93% 17
2023
Q1
$12.5M Sell
117,296
-10,607
-8% -$1.15M 1.98% 15
2022
Q4
$14.2M Sell
127,903
-637
-0.5% -$65.1K 2.6% 9
2022
Q3
$11.1M Buy
128,540
+306
+0.2% +$27.3K 2.15% 12
2022
Q2
$11.7M Sell
128,234
-21
-0% -$1.86K 2.13% 15
2022
Q1
$10.5M Buy
128,255
+352
+0.3% +$27.8K 1.62% 20
2021
Q4
$9.8M Buy
127,903
+778
+0.6% +$62K 1.44% 27
2021
Q3
$9.55M Buy
127,125
+1,658
+1% +$126K 1.53% 25
2021
Q2
$9.76M Sell
125,467
-3,800
-3% -$283K 1.56% 26
2021
Q1
$9.51M Buy
129,267
+2,312
+2% +$171K 1.67% 20
2020
Q4
$9.72M Buy
126,955
+1,092
+0.9% +$83.5K 1.57% 20
2020
Q3
$9.96M Buy
125,863
+778
+0.6% +$60.9K 1.87% 14
2020
Q2
$9.23M Buy
125,085
+75
+0.1% +$5.65K 1.89% 16
2020
Q1
$9.18M Buy
125,010
+25,257
+25% +$1.98M 2.26% 10
2019
Q4
$8.66M Sell
99,753
-1,876
-2% -$154K 1.72% 17
2019
Q3
$8.14M Buy
101,629
+3,075
+3% +$246K 1.7% 16
2019
Q2
$7.88M Buy
98,554
+215
+0.2% +$16.5K 1.77% 18
2019
Q1
$7.39M Buy
98,339
+2,164
+2% +$162K 1.67% 21
2018
Q4
$7.05M Buy
96,175
+2,238
+2% +$158K 1.8% 18
2018
Q3
$6.77M Buy
93,937
+4,008
+4% +$255K 1.63% 19
2018
Q2
$5.21M Buy
89,929
+1,365
+2% +$77K 1.39% 29
2018
Q1
$4.6M Buy
88,564
+1,060
+1% +$57.2K 1.32% 30
2017
Q4
$4.7M Sell
87,504
-104
-0.1% -$5.77K 1.36% 30
2017
Q3
$5.36M Buy
87,608
+53
+0.1% +$3.21K 1.8% 17
2017
Q2
$5.35M Buy
87,555
+1,719
+2% +$105K 1.76% 17
2017
Q1
$5.2M Buy
85,836
+3,358
+4% +$204K 1.89% 12
2016
Q4
$4.63M Buy
82,478
+682
+0.8% +$39.9K 1.75% 18
2016
Q3
$4.87M Buy
81,796
+419
+0.5% +$24.5K 1.95% 11
2016
Q2
$4.47M Buy
81,377
+246
+0.3% +$13.1K 1.82% 18
2016
Q1
$4.1M Buy
81,131
+4,365
+6% +$214K 1.76% 19
2015
Q4
$3.87M Buy
76,766
+4,318
+6% +$218K 1.69% 16
2015
Q3
$3.41M Buy
72,448
+4,800
+7% +$255K 1.55% 21
2015
Q2
$3.67M Buy
+67,648
New +$3.79M 1.6% 20

Other funds holding MRK

Whitney & Co's MRK Position: Q2 2026 in Review

Whitney & Co reduced its Merck (MRK) stake by 71% in Q2 2026, selling an estimated $9.11M and leaving 31,340 shares worth $4.03M. The position accounts for 0.29% of the portfolio, ranked #61.

Whitney & Co first reported a position in MRK in Q2 2015 and has held it in 45 quarters since. The position peaked at $14.8M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Whitney & Co held 31,340 shares of Merck worth $4.03M as of Q2 2026.
  • Whitney & Co sold 77,810 Merck shares in Q2 2026, an estimated $9.11M.
  • Merck made up 0.29% of Whitney & Co's portfolio in Q2 2026, its #61 holding.
  • Whitney & Co first reported a position in Merck in Q2 2015 and has held it in 45 quarters since.
  • Whitney & Co's Merck position peaked at $14.8M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.